Subjective Cognitive Decline (SCD)
40
20
24
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 40 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (40)
High Frequency Stimulation to Improve Cognition, Mobility, and Affect in Individuals With and Without Subjective Cognitive Decline
Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors
PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 Carriers
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
Personalized Brain Health Service and Dementia Prevention
InRAD Observational Study
Autophagy-Enhancers to Reduce Sleep Disturbances
Increasing Physical Activity Through Social Support and Stress Resilience
Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment
Study of Bedroom Environment Sleep Intervention at Home for Older Adults Living Alone With Memory Concerns
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
Expanding Access to Cognitive Health Biomarker Testing at Home
Predictors Of Cognitive Decline Using Digital Devices
Personalized Digital Training for COGnitive FITness in Mild Cognitive Impairment
FACE Phase II (a Stage II Trial)
Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
Art of Memory for Cognitive Enhancement in the Monza Brain Health Service
Lombard Cohort of Brain Health Services
Chinese Classics Recitation Training in Subjective Cognitive Decline
Physiological Effect of Non-invasive Photobiomodulation on Cognition and Mood in Older Adults With Subjective Cognitive Impairment